×
For best experience we recommend to activate Javascript in your browser.
Recombinant ALCAM (Praluzatamab Biosimilar) antibody
Research Grade
Reactivity: Human
Host: Humanized
Chimeric
unconjugated
Recombinant Antibody
Product Details anti-ALCAM (Praluzatamab Biosimilar) Antibody
(hide)
Target
ALCAM (Praluzatamab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for ALCAM (Praluzatamab Biosimilar) antibodies
Humanized
Expression System
Mammalian cells
Clonality
All clonalities for ALCAM (Praluzatamab Biosimilar) antibodies
Chimeric
Conjugate
All conjugates for ALCAM (Praluzatamab Biosimilar) antibodies
This ALCAM (Praluzatamab Biosimilar) antibody is un-conjugated
Application
Please inquire
Purpose
Research Grade Praluzatamab Biosimilar Antibody
Specificity
Activated leukocyte cell adhesion molecule, MEMD, CD166 antigen, ALCAM, CD166
Purification
Protein A or G purified from cell culture supernatant.
Purity
>95 % by SDS-PAGE.
Grade
Research Grade
Isotype
IgG1 kappa
Alternatives
(show)
Application Details
(hide)
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Buffer
0.01M PBS, pH 7.4.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Expiry Date
12 months
Target Details for ALCAM (Praluzatamab Biosimilar)
(hide)
Target
ALCAM (Praluzatamab Biosimilar)
Alternative Name
Praluzatamab Biosimilar
Target Type
Biosimilar
Background
Activated leukocyte cell adhesion molecule, MEMD, CD166 antigen, ALCAM, CD166
UniProt
Q13740
CAS-No
2145109-70-0
Recently viewed
(hide)